Recruiting studies: M Protein

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Stable Isotopes- Adults With Obesity
NA · 1 location(s) · University of Illinois at Urbana-Champaign · NCT07020741 Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT06539832 Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Li
Phase 3 · 78 location(s) · ArriVent BioPharma, Inc. · NCT07185997 Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT05686447 Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT06690593 Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD
Phase 2 · 3 location(s) · Peking University People's Hospital · NCT06418477 The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT05965115 National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852 (COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies
Phase N/A · 1 location(s) · Chang Gung Memorial Hospital · NCT05384509 Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
Phase 2 · 4 location(s) · Mayo Clinic · NCT05654506 A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT06082284 A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple My
Phase 2 · 39 location(s) · Regeneron Pharmaceuticals · NCT06140524 FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Pre
NA · 1 location(s) · University of Miami · NCT07446777

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.